Obesity and cardiovascular risk-Reference-Cited by-同舟云学术

Obesity and cardiovascular risk

Published:2018-07 Issue:7 Volume:36 Page:1441-1455
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Kotsis Vasilios,Tsioufis Konstantinos,Antza Christina,Seravalle Gino,Coca Antonio,Sierra Cristina,Lurbe Empar,Stabouli Stella,Jelakovic Bojan,Redon Josep,Redon Pau,Nilsson Peter M.,Jordan Jens,Micic Dragan,Finer Nicholas,Leitner Deborah R.,Toplak Hermann,Tokgozoglu Lale,Athyros Vasilios,Elisaf Moses,Filippatos Theodosios D.,Grassi Guido

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference189 articles.

1. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study;Stewart;Am J Med,2002

2. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study;Benjamin;Circulation,1998

3. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study;Krahn;Am J Med,1995

4. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study;Chugh;Circulation,2014

5. Epidemiology of atrial fibrillation: European perspective;Zoni-Berisso;Clin Epidemiol,2014

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the prevalence of obesity in a Russian adult population by six indices and their associations with hypertension, diabetes mellitus and hypercholesterolaemia;International Journal of Circumpolar Health;2024-08-06

2. In Silico İnvestigating Scutellarin, Plantago Majör Flavonoid as an Alternative to Orlistat;Caucasian Journal of Science;2024-08-02

3. Regulation of glycose and lipid metabolism and application based on the colloidal nutrition science properties of konjac glucomannan: A comprehensive review;Carbohydrate Polymers;2024-05

4. Assessment and Management of Patients with Obesity and Hypertension in European Society of Hypertension Excellence Centres. A survey from the ESH Working Group on Diabetes and Metabolic Risk Factors.;Blood Pressure;2024-02-26

5. Linea guida per la terapia del sovrappeso e dell’obesità resistenti al trattamento comportamentale nella popolazione adulta con comorbilità metaboliche;L'Endocrinologo;2024-01-31